从“先天伏寒”论治冠心病及其与神经内分泌免疫相关因子关系的研究
|
摘要
从“先天伏寒”论治冠心病及其与神经内分泌免疫相关因子关系的研究
冠状动脉粥样硬化性心脏病(以下简称冠心病)为心血管系统常见病、多发病,是临床和基础研究的热点和焦点。导师黄永生教授通过多年的临床实践,基于任继学教授对伏邪理论的深入认识,提出“男女媾精,阳气不足,寒伏于内”假说,创立“先天伏寒”病因学说,并总结出与之相应的有效治法和方药,在临床上从“先天伏寒”角度治疗冠心病收效确切。本文从理论探讨、临床研究和神经内分泌免疫网络相关因子的检测等不同侧面对冠心病从“先天伏寒”论治进行探讨和分析。
理论探讨
论述了“先天伏寒”病因学说提出的临床实践基础;运用中医理论,结合证候学研究的最新进展,对“先天伏寒”证候“气(阳)虚气滞、寒热错杂”的特点进行了探讨;阐述了“先天伏寒”病因学说提出的临床意义;对治疗“先天伏寒”证候的主方-伏寒方的立法组方用药特点进行了分析。
冠心病心绞痛“先天伏寒”证的临床表征回顾性研究
目的:采用数理统计多因素分析方法,结合临床实践,探讨“先天伏寒”证候特点,分析其主要症状和体征,以期为临床辨证规范化和标准化提供参考。
方法:采用黄永生教授收治的冠心病心绞痛患者门诊病案记录,按照标准入选病例,根据黄永生教授的当场判别,以“先天伏寒”证的有无分为试验组和对照组。对收集的症状和体征采用频数分析、因子分析、聚类分析和Logistic回归分析进行分析和处理。
结果:①“先天伏寒”证候患者均有足凉或手足凉的症状,以及特征性的演变病史。②“先天伏寒”证候以气(阳)虚气滞,寒热错杂为共性的特征,临床实际中也可以同时兼有血瘀、痰浊等不同的个性特征。③疲乏,善太息,心烦易怒,口干,舌淡隐青,脉沉对于“先天伏寒”证候的辨证具有较大的贡献度。
结论:运用中医理论对数理统计的结果进行分析,能够得出相对客观的“先天伏寒”证候临床表征信息,是进行辨证规范化和标准化研究的一种有效方法,值得深入探索。
伏寒颗粒干预冠心病心绞痛的临床研究试验1冠心病心绞痛“先天伏寒”兼血瘀证候的临床研究
目的:通过随机对照病例观察,评价伏寒颗粒合血府逐瘀颗粒对“先天伏寒”兼血瘀证候患者的治疗效应,并从方证相应角度,进一步探讨“先天伏寒”证候的临床表征特点。
方法:选取冠心病心绞痛“先天伏寒”兼血瘀证候患者60例,采用随机对照研究方法,分为试验组和对照组,试验组30例给予伏寒颗粒合血府逐瘀颗粒的混合制剂,1袋、2次/日;对照组给予金匮肾气丸10粒,2次/日,血府逐瘀颗粒1袋、2次/日;给药28天。观察心绞痛症状,“先天伏寒”证候和“血瘀”证候的症状、体征,心电图、不良反应及安全性指标(血尿常规、肝肾功能)。
结果:对疾病疗效、心绞痛疗效、不同时点心绞痛症状积分的改善,试验组均优于对照组;在心电图疗效、硝酸甘油停减情况方面,试验组与对照组比较无统计学意义,对于中医证候疗效、心血瘀阻证候积分、“先天伏寒”证候积分、中医总证候积分的改善,试验组优于对照组。试验组可明显改善胸痛、胸闷的冠心病心绞痛“血瘀”证候症状和足凉或手足凉、疲乏、太息、口干、心烦、胃痛或胀的“先天伏寒”证候症状,优于对照组。无明显不良反应,安全性指标无异常变化。
结论:从方证角度印证了“先天伏寒”证候临床表征与回顾性研究的一致性。“先天伏寒”证候-气(阳)虚气滞,寒热错杂-阴阳合治,寒热共调-伏寒方,在证-理-法-方-药的链条上存在着内在逻辑性和合理性。临床如能够针对“先天伏寒”证候特点进行治疗,会收到较好的疗效。
试验2冠心病心绞痛阳虚血瘀证候的临床研究
目的:通过随机对照病例观察,评价伏寒颗粒合血府逐瘀颗粒对阳虚血瘀证候患者的治疗效应。
方法:选取冠心病心绞痛阳虚血瘀证候患者60例,采用随机对照研究方法,分为试验组和对照组,试验组30例给予伏寒颗粒合血府逐瘀颗粒的混合制剂,1袋、2次/日;对照组给予金匮肾气丸10粒,2次/日,血府逐瘀颗粒1袋、2次/日;给药28天。观察心绞痛症状,阳虚血瘀证候的症状、体征,心电图、不良反应及安全性指标(血尿常规、肝肾功能)。
结果:对疾病疗效、心绞痛疗效、不同时点心绞痛症状积分、中医证候疗效、心电图疗效、硝酸甘油停减情况的改善,试验组与对照组比较无统计学意义。在改善阳虚血瘀证候症状方面,试验组可明显改善心悸、气短、疲乏症状,优于对照组。无明显不良反应,安全性指标无异常变化。
结论:伏寒颗粒合血府逐瘀颗粒对阳虚血瘀证候的治疗效应与金匮肾气丸合血府逐瘀颗粒相当,同时可以更好的改善心悸、气短、疲乏等症状。考虑可能与伏寒颗粒组方中专有针对气虚病机而设的药物组分,故疗效要相对明显。
小结:应用数理统计方法对回顾性临床资料分析得出的“先天伏寒”的证候特点可从方证相应角度与临床实际相互印证。在临证中,如能够同时针对“先天伏寒”病因进行治疗,可明显提高临床疗效。
冠心病“先天伏寒”证候与神经内分泌免疫相关因子关系的研究
目的:观察冠心病“先天伏寒”兼有血瘀证患者与冠心病阳虚血瘀证患者、亚健康状态“先天伏寒”证患者和健康对照组人群血液神经内分泌免疫相关因子的差异,探讨冠心病“先天伏寒”与神经内分泌免疫网络相关因子的关系。
方法:选择“伏寒颗粒干预冠心病心绞痛的临床研究”中纳入的冠心病心绞痛“先天伏寒”兼有血瘀证试验组和对照组共60例患者和冠心病心绞痛阳虚血瘀证患者30例,另外纳入亚健康状态的“先天伏寒”证候患者30例,健康对照组30例。用酶联免疫吸附法检测各组(包括冠心病心绞痛“先天伏寒”兼有血瘀证患者给药前后)血清hs-CRP、TNF-α、IL-6、ACTH和皮质醇含量。用RT-PCR法检测外周血细胞总RNA中TNF-α和IL-6 mRNA表达。
结果:将所有治疗前冠心病患者的结果整合为一组时,与健康组比较,冠心病组患者的血清IL-6、TNF-α、hs-CRP水平均有有明显升高,血清ACTH、皮质醇含量明显下降;冠心病组患者的全血TNF-αmRNA、IL-6 mRNA的表达增强;亚健康组血清IL-6、TNF-α明显升高,血清皮质醇、ACTH均有明显降低。
将所有治疗前冠心病“先天伏寒”兼有血瘀证候患者的结果整合到一组时,与冠心病阳虚血瘀证组比较,冠心病“先天伏寒”兼有血瘀证组血清hs-CRP含量升高显著,血清皮质醇、ACTH均显著下降。冠心病先天伏寒证候组给药后两组均可改善上述指标,但试验组对于血清TNF-α、皮质醇、ACTH含量和全血TNF-αmRNA表达的改善更为明显。
结论:“先天伏寒”证候的亚健康人群具有潜在性冠心病发病倾向和HPA轴功能低下。hs-CRP、ACTH、皮质醇紊乱可能为其证候特征的一部分。
Study on dealing with the treatment of coronary heart disease according to congenital latent cold and its correlated with correlative factors of neuro-endocrine-immunity network
Coronary heart disease(CHD) is a common and frequent disease of Cardiovascular System. It becomes the hotspot and focal point of fundamental and clinical research. Based on many years of clinical practice experience, professor huang yonghseng has put forward hypothesis as“men and women conbine together, deficiency of yang , cold hidden in the asthenia part”and proposed the etiology of chinese medicine theory: congenital latent cold. He also evolved corresponding therapeutic methods and Herbs. Such methods and herbs had definite therapeutic effect on CHD. This article sudy the“congenital latent cold”of CHD on such aspects as theory study, Retrospective Clinical Analysis, and detect correlation factor of neuro-endocrine-immunity network. Theoretical discussion
This part has discussed the clinical fundation of the proposal on“congenital latent cold”etiology theory according to clinical practice . applying the chinese medicine theory and reference to the recent development on science of syndrome , we discuss the the syndrome characteristics of pathogenic incubative cold, that is Qi(yang) Deficiency and Qi Stagnation, mixture of cold and heat syndrome. We also described the theoretical and clinical significance about the proposal of pathogenic incubative cold. and at last we analyzed the composing prescriptions and drug administering characteristics of fu han prescription which is the main clinical study treating the pathogenic incubative cold syndrome.
1. Retrospective studies on clinical characteristics of congenital latent cold Syndrome in coronary heart disease with angina pectoris.
Purpose: according to clinical practice, study the syndrome characteristics of“congenital latent cold”syndrome, analysis the main symptoms and signs,by using clinical epidemiological and mathematical statistics methods. To provide reference for differentiation of symptoms and signs of standardization.
Method: :adopt patient service case of Coronary atherosclerotic heart disease, according to the decide of professor huang yongsheng, divided into experiment group and control group according to if the patient has Pathogenic Incubative cold syndrome. Gathet the symptoms and signs, adopt frequence analysis, factor analysis, cluster analysis and Logistic regression analysis.
Result:①Patients of“congenital latent cold”syndrome have cold feet or cold limbs,and distinctive age rule.②the syndrome characteristics of“congenital latent cold”is Qi(yang) Deficiency and Qi Stagnation, mixture of cold and heat syndrome. It also can combine with blood stasis and phlegm.③Some symptom such as vexation, mouth dryness, preference for sighing, light purplish tongue, fatigue, pulse deep and weakened have a biggish contribution degree for differentiate the syndrome characteristics of“congenital latent cold”.
Conclusion: by analyzing the results of mathematical statistics using chinese medicine theory, we can obtain the relatively objective clinical manifestation of“congenital latent cold”syndrome. The method is an effective method for differentiation of symptoms and signs of standardization. It worth further explore.
2. Clinical mechanism studies of fu han granular preparation on treatment of coronary heart disease with angina pectoris
1) Clinical studies of congenital latent cold and blood stasis syndrome. of coronary heart disease with Angina Pectoris
Purpose: through randomized controlled trial, to evaluate the effects of fu han with xuefuzhuyu granular preparation in the treatment of CHD with angina pectoris of“congenital latent cold”syndrome,according to Prescription-Syndrome Corresponding Theory, study the clinical manifestation of Pathogenic Incubative cold syndrome.
Method: 60 patients with stable angina pectoris accoreded with diagnostic standards were selected and divided by randomly single blind into experiment group (30 cases), control group (30 cases),Fu han granulationes and xuefuzhuyu granulationes was dosed twice a day in experiment group,30 cases in experiment group were given Fu Han granulationes and XueFu ZhuYu granulationes 1 bag, twice a day. Fu Han granulationes and XueFu ZhuYu granulationes was dosed twice a day, JinKui ShenQi pills 10 pills was dosed twice a day in control group.
30 cases in control group were given Fu Han granulationes and XueFu ZhuYu granulationes, 1 bag, twice a day ,JinKui ShenQi pills,10 pills,twice a day.The treatment courses of the two groups lasted 28 days.To observe the sings and symptoms of angina pectoris, Pathogenic Incubative cold syndrome and blood stasis syndrome, electrocardiogram(ECG), the adverse effect, security test.
Result: Experiment group has a better effect than control group in The clinical curative effect, and The clinical curative effect of angina pectoris, and The Symptom score of angina pectoris before treatment ,14days and28 days. The clinical curative effect of ECG and discontinue rate of nitroglycerin, The experiment group compare with the control group,there was no significant difference. experiment group has a better effect than control group in The curative effect in clinical symptoms of traditional chinese medicine, and The Symptom score of congential latent cold syndrome and blood stasis syndrome. experiment group has good effects on improving the clinical symptoms of congential latent cold syndrome and blood stasis syndrome such as chest pain, dyspnea, cold feet,fatigue ,vexation, preference for sighing,mouth dryness, soreness of waist, stomachache. All the patients in two groups have no obvious adverse effects .
Conclusion: according to Prescription-Syndrome Corresponding Theory, the clinical manifestation of congential latent cold syndrome in accord with the results of retrospective studies. congential latent cold syndrome- Qi(yang)Deficiency and Qi Stagnation, mixture of cold and heat syndrome-adjust yin and yang ,regulate cold and heat-fu han prescription,it is a logical chain. If considering the importance of congential latent cold, we Can improve the clinical effects of CHD. 2) Clinical studies of yang Deficiency and blood stasis syndrome of coronary heart disease with angina pectoris
Purpose: through randomized controlled trial, to evaluate the effects of Fu Han with XueFu ZhuYu granular preparation in the treatment of coronary heart disease with angina pectoris of yang Deficiency and blood stasis syndrome.
Method: 60 patients of stable angina pectoris accoreded with diagnostic standards were selected and divided by randomly into experiment group (30 cases), control group (30 cases),Fu Han granulationes and XueFu ZhuYu granulationes was dosed twice a day in experiment group,30 cases in experiment group were given Fu Han granulationes and XueFu ZhuYu granulationes 1 bag, twice a day .Fu Han granulationes and XueFu ZhuYu granulationes was dosed twice a day,JinKui ShenQi pills ,10 pills was dosed twice a day in control group.
30 cases in control group were given Fu Han granulationes and XueFu ZhuYu granulationes, 1 bag,twice a day, JinKui ShenQi pills, 10 pills, twice a day. The treatment courses of the two groups lasted 28 days. To observe the sings and symptoms of angina pectoris, yang deficiency and blood stasis syndrome, electrocardiogram(ECG), the adverse effect, security test.
Result: Compare The clinical curative effect, and The clinical curative effect of angina pectoris, and The Symptom score of angina pectoris before treatment ,14 days and 28 days. The clinical curative effect of ECG and discontinue rate of nitroglycerin, The curative effect in clinical symptoms of traditional chinese medicine, there was no significant difference in two groups. experiment group has good effects on improving the clinical symptoms of yang Deficiency and blood stasis syndrome such as palpitations, breathe hard ,fatigue ,All patients in two groups have no obvious adverse effects .
Conclusion: Fu Han with XueFu ZhuYu granular preparation has a similar curative effect in the treatment of CHD with angina pectoris of yang Deficiency and blood stasis syndrome with JinKui ShenQi pills plus XueFu ZhuYu granular preparation. it has good effects on improving the clinical symptoms of yang deficiency and blood stasis syndrome such as palpitations, breathe hard ,fatigue. 3. Study on the relationship between congenital latent cold and blood stasis Syndrome of CHD and correlative factors of neuro-endocrine-immunity network
Purpose: observe and investigate the correlative factors of neuro-endocrine-immunity network in blood of patients of congenital latent cold and blood stasis syndrome, yang deficiency and blood stasis syndrome. Sub-health and health people,study the the relationship between congenital latent cold syndrome of CHD and correlative factors of neuro-endocrine-immunity network.
Method: 60 patients of stable angina pectoris accorded with congenital latent cold and blood stasis syndrome , 30 patients of stable angina pectoris accoreded with yang deficiency and blood stasis syndrome, 30 sub-health people accoreded with congenital latent cold and blood stasis syndrome , 30 heallth people as control group. to detect the serum level of hs-CRP, TNF-α, ACTH, IL-6 and Cortisolwith the ELISA Examination, to detect the gene expressive content of IL-6 and TNF-αin blood with Reverse Transcription–poly merasechain reaction(RT-PCR).
Result: Compare with the health control group , all CHD patients have a higher serum level of IL-6,TNF-α,hs-CRP and a lower serum level of ACTH and Cortisol,they alos have a more obvious gene expressive content of IL-6 and TNF-αin blood. Sub-health people also have a higer serum level of IL-6, TNF-αand a lower serum level of ACTH and Cortisol. Compare with the group of yang Deficiency and blood stasis syndrome, all patients of congenital latent cold and blood stasis syndrome have a higher serum level of hs-CRP and a lower serum level of ACTH and Cortisol. The group which given the treatment all improve the serum level ,but the experiment group which given the Fu Han with XueFu ZhuYu granular preparation has better effect on improve the serum level of TNF-α, Cortisol, ACTH and gene expressive content of TNF-αin blood.
Conclusion: The sub-health people with Pathogenic Incubative cold syndrome have potential outbreak of CHD and hypofunction of hypothalamic-pituitary-adre-nal axis, disorder of hs-CRP, ACTH, Cortisol may be part of the character of Pathogenic Incubative cold syndrome.
冠状动脉粥样硬化性心脏病(以下简称冠心病)为心血管系统常见病、多发病,是临床和基础研究的热点和焦点。导师黄永生教授通过多年的临床实践,基于任继学教授对伏邪理论的深入认识,提出“男女媾精,阳气不足,寒伏于内”假说,创立“先天伏寒”病因学说,并总结出与之相应的有效治法和方药,在临床上从“先天伏寒”角度治疗冠心病收效确切。本文从理论探讨、临床研究和神经内分泌免疫网络相关因子的检测等不同侧面对冠心病从“先天伏寒”论治进行探讨和分析。
理论探讨
论述了“先天伏寒”病因学说提出的临床实践基础;运用中医理论,结合证候学研究的最新进展,对“先天伏寒”证候“气(阳)虚气滞、寒热错杂”的特点进行了探讨;阐述了“先天伏寒”病因学说提出的临床意义;对治疗“先天伏寒”证候的主方-伏寒方的立法组方用药特点进行了分析。
冠心病心绞痛“先天伏寒”证的临床表征回顾性研究
目的:采用数理统计多因素分析方法,结合临床实践,探讨“先天伏寒”证候特点,分析其主要症状和体征,以期为临床辨证规范化和标准化提供参考。
方法:采用黄永生教授收治的冠心病心绞痛患者门诊病案记录,按照标准入选病例,根据黄永生教授的当场判别,以“先天伏寒”证的有无分为试验组和对照组。对收集的症状和体征采用频数分析、因子分析、聚类分析和Logistic回归分析进行分析和处理。
结果:①“先天伏寒”证候患者均有足凉或手足凉的症状,以及特征性的演变病史。②“先天伏寒”证候以气(阳)虚气滞,寒热错杂为共性的特征,临床实际中也可以同时兼有血瘀、痰浊等不同的个性特征。③疲乏,善太息,心烦易怒,口干,舌淡隐青,脉沉对于“先天伏寒”证候的辨证具有较大的贡献度。
结论:运用中医理论对数理统计的结果进行分析,能够得出相对客观的“先天伏寒”证候临床表征信息,是进行辨证规范化和标准化研究的一种有效方法,值得深入探索。
伏寒颗粒干预冠心病心绞痛的临床研究试验1冠心病心绞痛“先天伏寒”兼血瘀证候的临床研究
目的:通过随机对照病例观察,评价伏寒颗粒合血府逐瘀颗粒对“先天伏寒”兼血瘀证候患者的治疗效应,并从方证相应角度,进一步探讨“先天伏寒”证候的临床表征特点。
方法:选取冠心病心绞痛“先天伏寒”兼血瘀证候患者60例,采用随机对照研究方法,分为试验组和对照组,试验组30例给予伏寒颗粒合血府逐瘀颗粒的混合制剂,1袋、2次/日;对照组给予金匮肾气丸10粒,2次/日,血府逐瘀颗粒1袋、2次/日;给药28天。观察心绞痛症状,“先天伏寒”证候和“血瘀”证候的症状、体征,心电图、不良反应及安全性指标(血尿常规、肝肾功能)。
结果:对疾病疗效、心绞痛疗效、不同时点心绞痛症状积分的改善,试验组均优于对照组;在心电图疗效、硝酸甘油停减情况方面,试验组与对照组比较无统计学意义,对于中医证候疗效、心血瘀阻证候积分、“先天伏寒”证候积分、中医总证候积分的改善,试验组优于对照组。试验组可明显改善胸痛、胸闷的冠心病心绞痛“血瘀”证候症状和足凉或手足凉、疲乏、太息、口干、心烦、胃痛或胀的“先天伏寒”证候症状,优于对照组。无明显不良反应,安全性指标无异常变化。
结论:从方证角度印证了“先天伏寒”证候临床表征与回顾性研究的一致性。“先天伏寒”证候-气(阳)虚气滞,寒热错杂-阴阳合治,寒热共调-伏寒方,在证-理-法-方-药的链条上存在着内在逻辑性和合理性。临床如能够针对“先天伏寒”证候特点进行治疗,会收到较好的疗效。
试验2冠心病心绞痛阳虚血瘀证候的临床研究
目的:通过随机对照病例观察,评价伏寒颗粒合血府逐瘀颗粒对阳虚血瘀证候患者的治疗效应。
方法:选取冠心病心绞痛阳虚血瘀证候患者60例,采用随机对照研究方法,分为试验组和对照组,试验组30例给予伏寒颗粒合血府逐瘀颗粒的混合制剂,1袋、2次/日;对照组给予金匮肾气丸10粒,2次/日,血府逐瘀颗粒1袋、2次/日;给药28天。观察心绞痛症状,阳虚血瘀证候的症状、体征,心电图、不良反应及安全性指标(血尿常规、肝肾功能)。
结果:对疾病疗效、心绞痛疗效、不同时点心绞痛症状积分、中医证候疗效、心电图疗效、硝酸甘油停减情况的改善,试验组与对照组比较无统计学意义。在改善阳虚血瘀证候症状方面,试验组可明显改善心悸、气短、疲乏症状,优于对照组。无明显不良反应,安全性指标无异常变化。
结论:伏寒颗粒合血府逐瘀颗粒对阳虚血瘀证候的治疗效应与金匮肾气丸合血府逐瘀颗粒相当,同时可以更好的改善心悸、气短、疲乏等症状。考虑可能与伏寒颗粒组方中专有针对气虚病机而设的药物组分,故疗效要相对明显。
小结:应用数理统计方法对回顾性临床资料分析得出的“先天伏寒”的证候特点可从方证相应角度与临床实际相互印证。在临证中,如能够同时针对“先天伏寒”病因进行治疗,可明显提高临床疗效。
冠心病“先天伏寒”证候与神经内分泌免疫相关因子关系的研究
目的:观察冠心病“先天伏寒”兼有血瘀证患者与冠心病阳虚血瘀证患者、亚健康状态“先天伏寒”证患者和健康对照组人群血液神经内分泌免疫相关因子的差异,探讨冠心病“先天伏寒”与神经内分泌免疫网络相关因子的关系。
方法:选择“伏寒颗粒干预冠心病心绞痛的临床研究”中纳入的冠心病心绞痛“先天伏寒”兼有血瘀证试验组和对照组共60例患者和冠心病心绞痛阳虚血瘀证患者30例,另外纳入亚健康状态的“先天伏寒”证候患者30例,健康对照组30例。用酶联免疫吸附法检测各组(包括冠心病心绞痛“先天伏寒”兼有血瘀证患者给药前后)血清hs-CRP、TNF-α、IL-6、ACTH和皮质醇含量。用RT-PCR法检测外周血细胞总RNA中TNF-α和IL-6 mRNA表达。
结果:将所有治疗前冠心病患者的结果整合为一组时,与健康组比较,冠心病组患者的血清IL-6、TNF-α、hs-CRP水平均有有明显升高,血清ACTH、皮质醇含量明显下降;冠心病组患者的全血TNF-αmRNA、IL-6 mRNA的表达增强;亚健康组血清IL-6、TNF-α明显升高,血清皮质醇、ACTH均有明显降低。
将所有治疗前冠心病“先天伏寒”兼有血瘀证候患者的结果整合到一组时,与冠心病阳虚血瘀证组比较,冠心病“先天伏寒”兼有血瘀证组血清hs-CRP含量升高显著,血清皮质醇、ACTH均显著下降。冠心病先天伏寒证候组给药后两组均可改善上述指标,但试验组对于血清TNF-α、皮质醇、ACTH含量和全血TNF-αmRNA表达的改善更为明显。
结论:“先天伏寒”证候的亚健康人群具有潜在性冠心病发病倾向和HPA轴功能低下。hs-CRP、ACTH、皮质醇紊乱可能为其证候特征的一部分。
Study on dealing with the treatment of coronary heart disease according to congenital latent cold and its correlated with correlative factors of neuro-endocrine-immunity network
Coronary heart disease(CHD) is a common and frequent disease of Cardiovascular System. It becomes the hotspot and focal point of fundamental and clinical research. Based on many years of clinical practice experience, professor huang yonghseng has put forward hypothesis as“men and women conbine together, deficiency of yang , cold hidden in the asthenia part”and proposed the etiology of chinese medicine theory: congenital latent cold. He also evolved corresponding therapeutic methods and Herbs. Such methods and herbs had definite therapeutic effect on CHD. This article sudy the“congenital latent cold”of CHD on such aspects as theory study, Retrospective Clinical Analysis, and detect correlation factor of neuro-endocrine-immunity network. Theoretical discussion
This part has discussed the clinical fundation of the proposal on“congenital latent cold”etiology theory according to clinical practice . applying the chinese medicine theory and reference to the recent development on science of syndrome , we discuss the the syndrome characteristics of pathogenic incubative cold, that is Qi(yang) Deficiency and Qi Stagnation, mixture of cold and heat syndrome. We also described the theoretical and clinical significance about the proposal of pathogenic incubative cold. and at last we analyzed the composing prescriptions and drug administering characteristics of fu han prescription which is the main clinical study treating the pathogenic incubative cold syndrome.
1. Retrospective studies on clinical characteristics of congenital latent cold Syndrome in coronary heart disease with angina pectoris.
Purpose: according to clinical practice, study the syndrome characteristics of“congenital latent cold”syndrome, analysis the main symptoms and signs,by using clinical epidemiological and mathematical statistics methods. To provide reference for differentiation of symptoms and signs of standardization.
Method: :adopt patient service case of Coronary atherosclerotic heart disease, according to the decide of professor huang yongsheng, divided into experiment group and control group according to if the patient has Pathogenic Incubative cold syndrome. Gathet the symptoms and signs, adopt frequence analysis, factor analysis, cluster analysis and Logistic regression analysis.
Result:①Patients of“congenital latent cold”syndrome have cold feet or cold limbs,and distinctive age rule.②the syndrome characteristics of“congenital latent cold”is Qi(yang) Deficiency and Qi Stagnation, mixture of cold and heat syndrome. It also can combine with blood stasis and phlegm.③Some symptom such as vexation, mouth dryness, preference for sighing, light purplish tongue, fatigue, pulse deep and weakened have a biggish contribution degree for differentiate the syndrome characteristics of“congenital latent cold”.
Conclusion: by analyzing the results of mathematical statistics using chinese medicine theory, we can obtain the relatively objective clinical manifestation of“congenital latent cold”syndrome. The method is an effective method for differentiation of symptoms and signs of standardization. It worth further explore.
2. Clinical mechanism studies of fu han granular preparation on treatment of coronary heart disease with angina pectoris
1) Clinical studies of congenital latent cold and blood stasis syndrome. of coronary heart disease with Angina Pectoris
Purpose: through randomized controlled trial, to evaluate the effects of fu han with xuefuzhuyu granular preparation in the treatment of CHD with angina pectoris of“congenital latent cold”syndrome,according to Prescription-Syndrome Corresponding Theory, study the clinical manifestation of Pathogenic Incubative cold syndrome.
Method: 60 patients with stable angina pectoris accoreded with diagnostic standards were selected and divided by randomly single blind into experiment group (30 cases), control group (30 cases),Fu han granulationes and xuefuzhuyu granulationes was dosed twice a day in experiment group,30 cases in experiment group were given Fu Han granulationes and XueFu ZhuYu granulationes 1 bag, twice a day. Fu Han granulationes and XueFu ZhuYu granulationes was dosed twice a day, JinKui ShenQi pills 10 pills was dosed twice a day in control group.
30 cases in control group were given Fu Han granulationes and XueFu ZhuYu granulationes, 1 bag, twice a day ,JinKui ShenQi pills,10 pills,twice a day.The treatment courses of the two groups lasted 28 days.To observe the sings and symptoms of angina pectoris, Pathogenic Incubative cold syndrome and blood stasis syndrome, electrocardiogram(ECG), the adverse effect, security test.
Result: Experiment group has a better effect than control group in The clinical curative effect, and The clinical curative effect of angina pectoris, and The Symptom score of angina pectoris before treatment ,14days and28 days. The clinical curative effect of ECG and discontinue rate of nitroglycerin, The experiment group compare with the control group,there was no significant difference. experiment group has a better effect than control group in The curative effect in clinical symptoms of traditional chinese medicine, and The Symptom score of congential latent cold syndrome and blood stasis syndrome. experiment group has good effects on improving the clinical symptoms of congential latent cold syndrome and blood stasis syndrome such as chest pain, dyspnea, cold feet,fatigue ,vexation, preference for sighing,mouth dryness, soreness of waist, stomachache. All the patients in two groups have no obvious adverse effects .
Conclusion: according to Prescription-Syndrome Corresponding Theory, the clinical manifestation of congential latent cold syndrome in accord with the results of retrospective studies. congential latent cold syndrome- Qi(yang)Deficiency and Qi Stagnation, mixture of cold and heat syndrome-adjust yin and yang ,regulate cold and heat-fu han prescription,it is a logical chain. If considering the importance of congential latent cold, we Can improve the clinical effects of CHD. 2) Clinical studies of yang Deficiency and blood stasis syndrome of coronary heart disease with angina pectoris
Purpose: through randomized controlled trial, to evaluate the effects of Fu Han with XueFu ZhuYu granular preparation in the treatment of coronary heart disease with angina pectoris of yang Deficiency and blood stasis syndrome.
Method: 60 patients of stable angina pectoris accoreded with diagnostic standards were selected and divided by randomly into experiment group (30 cases), control group (30 cases),Fu Han granulationes and XueFu ZhuYu granulationes was dosed twice a day in experiment group,30 cases in experiment group were given Fu Han granulationes and XueFu ZhuYu granulationes 1 bag, twice a day .Fu Han granulationes and XueFu ZhuYu granulationes was dosed twice a day,JinKui ShenQi pills ,10 pills was dosed twice a day in control group.
30 cases in control group were given Fu Han granulationes and XueFu ZhuYu granulationes, 1 bag,twice a day, JinKui ShenQi pills, 10 pills, twice a day. The treatment courses of the two groups lasted 28 days. To observe the sings and symptoms of angina pectoris, yang deficiency and blood stasis syndrome, electrocardiogram(ECG), the adverse effect, security test.
Result: Compare The clinical curative effect, and The clinical curative effect of angina pectoris, and The Symptom score of angina pectoris before treatment ,14 days and 28 days. The clinical curative effect of ECG and discontinue rate of nitroglycerin, The curative effect in clinical symptoms of traditional chinese medicine, there was no significant difference in two groups. experiment group has good effects on improving the clinical symptoms of yang Deficiency and blood stasis syndrome such as palpitations, breathe hard ,fatigue ,All patients in two groups have no obvious adverse effects .
Conclusion: Fu Han with XueFu ZhuYu granular preparation has a similar curative effect in the treatment of CHD with angina pectoris of yang Deficiency and blood stasis syndrome with JinKui ShenQi pills plus XueFu ZhuYu granular preparation. it has good effects on improving the clinical symptoms of yang deficiency and blood stasis syndrome such as palpitations, breathe hard ,fatigue. 3. Study on the relationship between congenital latent cold and blood stasis Syndrome of CHD and correlative factors of neuro-endocrine-immunity network
Purpose: observe and investigate the correlative factors of neuro-endocrine-immunity network in blood of patients of congenital latent cold and blood stasis syndrome, yang deficiency and blood stasis syndrome. Sub-health and health people,study the the relationship between congenital latent cold syndrome of CHD and correlative factors of neuro-endocrine-immunity network.
Method: 60 patients of stable angina pectoris accorded with congenital latent cold and blood stasis syndrome , 30 patients of stable angina pectoris accoreded with yang deficiency and blood stasis syndrome, 30 sub-health people accoreded with congenital latent cold and blood stasis syndrome , 30 heallth people as control group. to detect the serum level of hs-CRP, TNF-α, ACTH, IL-6 and Cortisolwith the ELISA Examination, to detect the gene expressive content of IL-6 and TNF-αin blood with Reverse Transcription–poly merasechain reaction(RT-PCR).
Result: Compare with the health control group , all CHD patients have a higher serum level of IL-6,TNF-α,hs-CRP and a lower serum level of ACTH and Cortisol,they alos have a more obvious gene expressive content of IL-6 and TNF-αin blood. Sub-health people also have a higer serum level of IL-6, TNF-αand a lower serum level of ACTH and Cortisol. Compare with the group of yang Deficiency and blood stasis syndrome, all patients of congenital latent cold and blood stasis syndrome have a higher serum level of hs-CRP and a lower serum level of ACTH and Cortisol. The group which given the treatment all improve the serum level ,but the experiment group which given the Fu Han with XueFu ZhuYu granular preparation has better effect on improve the serum level of TNF-α, Cortisol, ACTH and gene expressive content of TNF-αin blood.
Conclusion: The sub-health people with Pathogenic Incubative cold syndrome have potential outbreak of CHD and hypofunction of hypothalamic-pituitary-adre-nal axis, disorder of hs-CRP, ACTH, Cortisol may be part of the character of Pathogenic Incubative cold syndrome.
引文
[1]孙永章.从气阴着眼治疗冠心病[J].中国中医基础医学杂志, 1998, 4(11): 6-7.
[2]杨传彪,周民权.论补养心阴法是治疗冠心病的重要方法[J].中国中医基础医学杂志, 1998, 4(6): 45-47.
[3]欧阳智兴,欧阳博文.补肾固本对治疗冠心病的作用[J].中国中医药信息杂志, 2002, 9 (4): 7-8.
[4]包培蓉,吕同杰.从火邪论治心绞痛[J].中国中医急症,1994,3(3):120-121.
[5]吴伟,彭锐.冠心病热毒病机的探讨[J].新中医,2007, 39(6): 3-4.
[6]吴伟,邝枣园,黄衍寿,等.肺炎衣原体感染致冠心病的研究进展及中医药防治对策[J].广州中医药大学学报, 2002, 19(1): 77-80.
[7]丁书文,王晓,李运仑.热毒学说在心系疾病中的构建与应用[J].山东中医药大学学报, 2004, 28(61): 413-416.
[8]李晓,姜萍.关于胸痹心痛之郁热伤络病机[J].中医杂志, 2003, 44(8): 636-637.
[9]解民.从肝论治冠心病心绞痛的临床观察[J].吉林中医药, 2002, 22(4): 5.
[10]马爱萍,郭海涛.调肝脾防治中青年心身冠心病的体会[J].辽宁中医杂志, 2005, 32(2): 133-134.
[11]陈可冀,史载祥.实用血瘀证学[M].北京:人民卫生出版社, 1999: 261.
[12]张明雪,曹洪欣,吴东宁.论“血瘀”在冠心病发病中的作用[J].中国中医基础医学杂志, 2009, 15 (2): 128-131.
[13]沈绍功.诊治冠心病的新思路[J].中国中医急症, 1999, 8(2): 51-53.
[14]马宁,安冬青,朱萌,等.秽浊痰阻型冠心病(胸痹)脾胃虚损之探[J].新疆中医药, 2009, 27(1): 13-15.
[15]倪量,杨培君.冠心病“治痰为先”的临床思路探讨[J].中国中医急症, 2004, 13(1): 25-26.
[16]张明雪,曹洪欣,常艳鹏,等.论“寒邪”在冠心病发病中的作用[J].中医药学报, 2009, 37(3): 1-4.
[17]何庆勇,施展,李霁,等.陈鼎祺教授治疗冠心病的经验[J].时珍国医国药, 2007, 18(11): 2612-2613.
[18]孟繁蕴,翟聚良,张艳东.周次清教授治疗冠心病经验[J].四川中医, 2002, 20(6): 9.
[19]王侠,陈秋雄,昊焕林.《金匮要略》助阳扶正法与冠心病诊治[J].山东中医杂志, 2005, 24(10): 635.
[20]郝现军,王冠民.冠心病证治心得[J].陕西中医学院学报, 2008, 31(1): 28-29.
[21]胡少红.浅谈气虚为冠心病之本[J].吉林中医药, 2005, 25(11): 5-6.
[22]牟大鹏.辨证治疗以胸闷为主症冠心病浅识[J].实用中医内科杂志, 2007, 21(7): 29.
[23]武志平,闫桂玲.益气化痰汤治疗冠心病心绞痛37例[J].陕西中医, 2002, 23(8): 679.
[24]王忠良,钱士明,张寒梅.冠心病不稳定型心绞痛病机初探[J].湖南中医杂志, 2005, 21(6): 58-59.
[25]曹洪欣,张明雪.试论冠心病病机与阳虚痰瘀[J].中医药通报, 2002, 1(6): 1-3.
[26]赵军礼,钟少昕.陈镜合教授从郁论治冠心病经验[J].新中医, 2000, 32(4): 11-12.
[27]冯云萍.冠心病心绞痛的中医治疗体会[J].山西医药杂志, 2007, 36(8): 616-617.
[28]喻秀兰,梅国强.诊治冠心病的经验[J].湖北中医杂志, 2004, 26(10): 17-18.
[29]秦建国.胸痹心痛病机新论[J].辽宁中医杂志, 2004, 31(10): 815-816.
[30]吴焕林,林晓忠,邹旭.邓铁涛治疗冠心病临床经验探析[J].辽宁中医学院学报, 2005, 7(4): 312-313.
[31]吴伟康,邓铁涛.邓老“痰瘀相关”理论与冠心病防治[J].深圳中西医结合杂志, 2006, 16(1): 13-16.
[32]李柳骥,严季澜.试论扶阳在心绞痛治疗中的地位及含义[J].中华中医药杂志(原中国医药学报), 2009, 24 (7): 840-842.
[33]沈金玲.温法治疗老年冠心病探析[J].中医研究, 2008, 21( 6): 6-8.
[34]颜乾麟,颜德馨.审机论治冠心病经验[J].中国中医药信息杂志. 2009, 16(2): 88-89.
[35]樊瑞红,马连珍.温阳活血法治疗冠心病心绞痛经验[J].辽宁中医杂志, 2002, 29(2): 72.
[36]吴岳.董克礼教授诊治中老年冠心病经验[J].湖南中医杂志, 2006, 22(1): 20-22.
[37]赵红.老年冠心病心绞痛的辨治体会[J].光明中医, 2005, 20(1): 10.
[38]姜淑琴.冠心病从肾论治浅谈[J].中国中医急症, 2005, 14(3): 275.
[39]姜春梅,查杰,尹远平,等.五脏一体—论治冠心病学术思想探讨[J].中医药学刊, 2005, 23(4): 597-598.
[40]吴以岭.从络病学说论治冠心病心绞痛[J].中国中医基础医学杂志, 2001, 7(4): 71-74.
[41]王淑芹.益气活血祛风通络治疗冠心病心绞痛100例[J].山东中医杂志, 1995, 14(2): 67-68.
[42]戴国华.冠心病风病说[J].山东中医药大学学报, 2003, 27(3): 172-174.
[43]刘杨,吕懋庸,罗洪林.六经辨治冠心病临证思路探讨[J].四川中医, 2008, 26(8): 28-29.
[44]张光银,张军平.从病证结合谈冠心病大气下陷证[J].吉林中医药, 2009, 29(4): 283-284.
[45]张京春,谢元华,蒋跃绒,等.陈可冀辨治冠心病医案证法方药的频数分析[J].中医杂志, 2008, 49(10): 901-902.
[46]吴荣,王阶,任廷革,等.基于数据挖掘的名老中医冠心病诊疗规律研究[J].中华中医药学刊, 2008, 26(12): 2581-2583.
[1]中国中西医结合学会心血管学会.冠心病的中医辨证标准[S].中西医结合杂志, 1991, 11(5): 257.
[2]陈贵廷,薛赛琴.最新国内外痰病诊疗标准[S].北京:学苑出版社. 1992: 209-212.
[3]吴凯.国家中医药管理局医政司胸痹急症协作组[J].中国中医急症, 1994, 3(1): 47.
[4]中华人民共和国卫生部.中药新药临床研究指导原则[M].北京:人民卫生出版社, 1993: 41-45.
[5]国家中医药管理局.中医病证诊断疗效标准[S].南京:南京大学出版社, 1994: 18-19.
[6]中华人民共和国卫生部.中药新药治疗冠心病心绞痛的临床研究指导原则(试行)[M].北京:中国医药科技出版社, 2002: 68-73.
[7]王永炎.中医内科学[M]. 6版.上海:上海科学技术出版社, 1997: 108-117.
[8]周仲瑛.中医内科学[M]. 7版.北京:中医药出版社, 2007: 135-146.
[9]吴旸,王轩,崔杰,等. 348例冠心病患者中医证候特点因子分析[J].中华中医药学刊, 2009, 27(2): 392-394.
[10]吴焕林,阮新民,杨小波,等. 319例冠心病患者证候分布规律分析[J].中国中西医结合杂志, 2007, 27(6): 498-500.
[11]贾振华,王永军,吴以岭,等.基于熵的复杂系统分划方法与冠心病心绞痛证候要素提取及其分布规律[J].第二军医大学学报, 2007, 28(7): 775-777.
[12]王阶,邢雁伟,姚魁武,等.冠心病心绞痛中医证候要素研究及临床应用[J].湖北中医学院学报, 2009, 11(3): 3-5.
[13]王晓才,农一兵,林谦,等. 138例冠心病患者的证候分布与组合特点分析[J].中医杂志, 2008, 49(1): 62-66.
[14]郑峰,曲丹,徐浩,等.冠心病稳定期患者中医辨证与超敏C反应蛋白相关性研究[J].中国中西医结合杂志, 2009, 29(6): 485-488.
[15]商秀洋,石洁.冠心病中医辨证与血清高敏C反应蛋白的关系研究现代中西医结合杂志[J]. 2008, 17(6): 818-819.
[16]张继红,苗志林,刘冬梅,等.冠心病中医证型与血管内皮功能指标的相关性分析[J].心血管康复医学杂志, 2006, 15(2): 186-187.
[17]王阶,邢雁伟,陈建新,等. 1069例冠心病患者冠状动脉造影与中医证候特点[J].中西医结合学报, 2008, 6(2): 148-152.
[18]董国菊,刘剑刚,王承龙,等. 300例冠心病患者中医证型分布特点分析[J].环球中医药, 2009, 2(2): 96-98.
[19]何庆勇,王阶,张允岭,等.女性冠心病中医证候学及冠脉病变特点研究[J].中国中西医结合杂志, 2009, 29(10): 879-882.
[20]何庆勇,王阶,姚魁武,等. 1069例冠心病脏腑虚证的多中心前瞻性研究[J].中华中医药杂志(原中国医药学报), 2009, 24(1): 31-33.
[21]吴辉,于扬文,吴伟,等. 116例冠心病患者中医证候及病因分析[J].江苏中医药, 2004, 25(10): 30-31.
[22]张京春,谢元华,蒋跃绒,等.陈可冀辨治冠心病医案证法方药的频数分析[J].中医杂志, 2008, 49(10): 901-902.
[23]吴荣,王阶,任廷革,等.基于数据挖掘的名老中医冠心病诊疗规律研究[J].中华中医药学刊, 2008, 26(12): 2581-2583.
[24]王阶,吴荣,周雪忠.基于支持向量机的名老中医治疗冠心病证候要素研究[J].北京中医药大学学报, 2008, 31(8): 540-543.
[25]其其格,王伟,胡立胜,等. 9790例冠心病心绞痛辨证分型文献统计分析[J].山酉中医, 2008, 24(10): 31-33.
[26]李军,王阶.冠心病心绞痛证候要素与应证组合的5099例文献病例分析[J].中国中医基础医学杂志, 2007, 13(12): 926-930.
[27]陈一清,吴礼胜.冠心病心绞痛辨证施治若干问题探讨[J].中国中医急症, 2005, 14(7): 654-656.
[28]张琳,于鑫婷,徐浩.冠心病中医证候特点的分析与思考[J].中西医结合心脑血管病杂志, 2009, 7(5): 578-581.
[29]管恩泽,朱萱萱,王广基,等.冠心病中医辨证分型与临床指标相关性研究[J].中华中医药学刊, 2008, 26(10): 2249-2251.
[30]王宇军,胡利荣.冠心病患者冠状动脉CTA与中医辨证分型关系分析[J].浙江中医杂志, 2009, 44(6): 408.
[31]邢雁伟,李尊,王阶,等.冠脉病变特征和中医证候要素关系的研究[J].辽宁中医杂志, 2008, 35(l): 36-38.
[32]王子宽,柳荫,刘军,等.冠心病患者冠状动脉病变范围及狭窄程度与中医证型相关性分析[J].陕西中医, 2009, 30(2): 134-135.
[33]林冬群,曾敏然,林宇,等.冠心病患者冠状动脉搭桥手术围手术期中医证候分布和演变规律初探[J].广州中医药大学学报, 2009, 26(2): 188-190.
[34]王阶,李军,姚魁武,等.冠心病心绞痛证候要素和冠脉病变的Logistic回归分析[J].辽宁中医杂志, 2007, 34(9): 1209-1211.
[35]徐浩,鹿小燕,陈可冀,等.血瘀证及其兼证与冠脉造影所示病变及介入治疗后再狭窄的相关性研究[J].中国中西医结合杂志, 2007, 27(1): 8-13.
[36]杜建强,吴万垠,毛炜,等. SPECT在冠心病中医辨证中的应用[J].中医药临床杂志, 2007, 1(3): 282-283.
[37]丁邦晗,杨敏,周珂,等.胸痹心痛患者心电图改变与中医证型的关系[J].中国中西医结合急救杂志, 2008, 15(1): 31-33.
[38]戴跃龙,李方洁,杨阳.气阴两虚证(冠心病、糖尿病)心率变异性时域指标研究[J].黑龙江中医药, 2009, 38(6): 4-5.
[39]王玉燕,杜武勋,魏营,等.冠心病不同证型与颈动脉内-中膜厚度关系的研究[J].山西中医, 2009, 25(2): 34-36.
[40]杨东辉,孙博,郭艳艳.冠心病患者中医证型与颈动脉内膜-中层厚度及踝臂指数的相关性研究[J].云南中医中药杂志, 2009, 30(9): 5-6.
[41]褚田明,顾仁樾.冠心病阳虚证与心功能减退关系的研究-附262例临床资料[J].江苏中医药, 2007, 39(6): 17-18.
[42]唐巍,遇红,李江涛.冠心病患者血中胰岛素、胰高血糖素与中医证候类型关系的研究[J].中国中医基础医学杂志, 2002, 8(9): 53/693-55/695.
[43]郭平清,林求诚,郭银庚,等.高密度脂蛋白磷脂对冠心病肾阳虚证的诊断作用[J].中国中西医结合急救杂志, 2003, 10(4):223-225.
[44]赵明君,薛强,雷瑗琳.冠心病患者血清瘦素水平与中医证候的相关性研究[J].陕西中医, 2008, 29(2): 132-133.
[45]龙卫平,石磊,韦爱欢,等.冠心病中医辨证分型与内皮损伤、炎症反应及血小板活化的相关性研究[J].广州中医药大学学报, 2008, 25(5): 457-460.
[46]袁肇凯,黄献平,谭光波,等.冠心病血瘀证血管内皮细胞功能的检测分析[J].中国中西医结合杂志, 2006, 26(5): 407-410.
[47]杨徐杭,汶医宁,党琳,等.冠心病中医辨证与血清E-选择素、细胞间粘附分子-1的关系研究[J].四川中医, 2008, 26(1): 61-62.
[48]袁肇凯,黄献平,简维雄,等.冠心病辨证与血凝纤溶系统关系的临床研究[J].云南中医学院学报, 2009, 32(3): 1-4.
[49]杨徐杭,汶医宁,王军威.肺炎衣原体感染与冠心病中医证候的关系[J].陕西中医学院学报, 2009, 32(1): 20-21.
[50]杨徐杭,汶医宁,王军威,等.冠心病中医辨证与血清IL-18、sCD40L的关系[J].江苏中医药, 2009, 41(3):31-32.
[51]卢玉俊,石磊.冠心病中医证型与血浆同型半胱氨酸水平相关性的研究[J].浙江中医药大学学报, 2009, 33(1): 103-104.
[52]杨徐杭,汶医宁,王军威.基质金属蛋白酶-9与冠心病中医证候的关系[J].陕西中医, 2009, 30(2): 131-132.
[53]杨军辉,欧阳玉燕.内皮细胞损伤与冠心病心绞痛血瘀证四亚型的相关性研究[J].中国中医药现代远程教育, 2009, 7(5): 14-16.
[54]杨保林,王阶,姜燕.冠心病血瘀证相关基因b13的筛查和临床验证[J].中国中医基础医学杂志, 2007, 13(1): 69-71.
[55]杨保林,王阶,姜燕.冠心病血瘀证相关基因研究[J].世界科学技术-中医药现代化基础研究, 2005,7(1):16-19.
[56]李炜弘,王米渠,王刚,等.冠心病心阳虚证相关差异表达基因分析[J].现代中西医结合杂志, 2004, 13( 24): 3219-3222.
[57]洪永敦,朱会英,陈宇鹏,等.冠心病痰瘀证候与E选择素G98T及S128R基因多态性的关系研究[J].广州中医药大学学报, 2009, 26(1): 1-5.
[58]赵慧辉,候娜,王伟,等.冠心病气虚血瘀证的蛋白质组学特征研究[J].中国中西医结合杂志, 2009, 29(6): 489-492.
[59]杨俊华,杨国靖,刘茹.冠心病患者A型性格与情绪障碍及中医辨证分型关系的探讨[J].中国中医药信息杂志, 2009, 16(8): 23-25.
[1]黄永生,郭家娟,邓悦.先天伏寒证理论内涵及其对临床指导意义[J].实用中医内科杂志, 2007, 21(6): 3-4.
[2]任继学.伏邪探微[J].长春中医学院学报, 2005, 21(1): 4-7.
[3]恩格斯.自然辩证法[M].北京,人民出版社, 1971: 218.
[4]张晓华,黄永生.稳心2号方治疗冠心病心绞痛临床80例观察[J].中国社区医师, 2005, 6(7): 44-46.
[5]黄永生.冠心病心绞痛临床诊治体会[J].长春中医学院学报, 2005, 21(1): 16-17.
[6]于双成,张元秋,袁长吉.从科学假说与临床诊断的相似性阐述类比推理方法学意义[J].中国高等医学教育, 2009, (5): 94-95.
[7]贾春华,王永炎,黄启福,等.从逻辑的观点看-“以象为素,以素为候,以候为证”[J].北京中医药大学学报, 2006, 29(1): 5-7.
[8]王永炎,张志斌.再议完善辨证方法体系的几个问题[J].天津中医药, 2007, 24(1): 1-4.
[9]刘保延,王永炎.证候、证、症的概念及其关系的研究[J].中医杂志, 2007, 48(4): 293-298.
[10]王永炎,张启明,张志斌.证候要素及其靶位的提取[J].山东中医药大学学报, 2006, 30(1): 6-7.
[11]吴荣,王阶,任廷革,等.基于数据挖掘的名老中医冠心病诊疗规律研究[J].中华中医药学刊, 2008, 26(12): 2581-2583.
[12]吉瑞瑞,李付英,张雪静,等.淫羊藿苷对缺氧诱导血管内皮细胞损伤的保护作用[J].中国中西医结合杂志, 2005, 25(6): 525-530.
[13]李梨,周岐新,杨俊卿,等.淫羊藿苷和尼莫地平对脑缺血再灌小鼠行为学变化的影响[J].中国行为医学科学, 2005, 14(8): 687-689.
[14]武敬亮,苏智先,田桂香,等.淫羊藿研究新进展[J].中医药学报, 2004, (3): 134.
[15]付嘉,熊彬,郑冰生,等.巴戟天对D-半乳糖致衰老小鼠抗氧化系统作用的实验研究[J].中国老年学杂志, 20004, 24: 1206.
[16]赵胜,冯国清,付润芳,等.巴戟天水提物对大鼠心肌缺血再灌注损伤的保护作用[J].浙江中医杂志, 2005, 40(3): 124-126.
[17]张贺鸣,韩联合,冯国清,等.巴戟天对培养乳鼠心肌细胞缺氧复氧损伤的防护作用[J].河南中医学院学报, 2005, 20(8): 20-21.
[1]国际心脏病学会和协会及世界卫生组织临床命名标准化联合专题组.缺血性心脏病的命名及诊断标准[S].中华心血管病杂志, 1981, 9(1): 75-76.
[2]黄永生,郭家娟,邓悦.先天伏寒证理论内涵及其对临床指导意义[J].实用中医内科杂志, 2007, 21(6): 3-4.
[3]刘保延,王永炎.证候、证、症的概念及其关系的研究[J].中医杂志, 2007, 48(4): 293-298.
[4]王永炎,张志斌.再议完善辨证方法体系的几个问题[J].天津中医药, 2007, 24(1): 1-4.
[5]吕爱平,李梢,王永炎.从主观症状的客观规律探索中医证候分类的科学基础[J].中医杂志, 2005, 46(1): 4-6.
[6]王映辉,姜在旸,刘保延,等.基于信息和数据挖掘技术的名老中医临床诊疗经验研究思路[J].世界科学技术-中医药现代化, 2005, 7(1): 98-105.
[7]袁世宏,王米渠,王天芳,等.聚类分析对肾虚症状的探索性研究[J].北京中医药大学学报, 2006, 29(4): 254-257.
[8]魏华凤,季光,郑培永.证候诊断规范化研究的现状分析[J].中西医结合学报, 2007, 5(2): 115-121.
[9]于春光.基于多种数据分析方法的慢性乙型肝炎证候要素的研究[D].北京:北京中医药大学, 2007: 1-4.
[10]王泓午,王玉来,金章安,等.缺血性中风发病前7~30 d内症状的病例对照研究[J].天津中医药, 2004, 21(6): 470-473.
[11]李永健,方肇勤,唐辰龙,等. 154例原发性肝癌临床症状多元Logistic回归分析[J].中国中医基础医学杂志, 2003, 9(8): 59-62.
[12]陈建设,谢世平,许前磊,等.艾滋病常见实证量化诊断的Logistic回归分析[J].中医杂志, 2009, 50(7): 632-634.
[13]陈建设,陈文垲.聚类分析结合logistic回归分析在中医证候诊断量化研究中的应用探讨[J].中国卫生统计, 2009, 26(4): 379-381.
[14]王红玉.亚健康状态378例40项症状分析述评[J].中医药学刊, 2004, 22(4): 624-625.
[15]王莹莹,杨金生. 216例中风病急性期痰热腑实证患者症状分析[J].北京中医药大学学报, 2008, 31(5): 347-350.
[16]范军铭,董永书,王守富. 1760例高血压患者中医症状分析[J].中国中医基础医学杂志, 2009, 15(6): 452-454.
[17]李峰,关静,黄焕光,等.静脉吸毒感染HIV与吸毒人群症状分布特征的病例对照研究[J].北京中医药大学学报, 2006, 29(6): 422-425.
[18]吴秀艳,王天芳,陈建新,等.基于关联度法的抑郁症、慢性乙型肝炎、慢性肾功能衰竭病性类证候要素与症状相关性的研究[J].天津中医药, 2009, 26(5): 433-435.
[19]何羿婷,查青林,阎小萍,等.类风湿性关节炎症状因子分析及其与疗效的关系[J].中国中西医结合杂志, 2005, 25(12): 1077-1081.
[20]李建婷,邓兆智,郭新峰,等.类风湿性关节炎中医证候诊断中特征信息的选择[J].广州中医药大学学报, 2009, 26(4): 398-401.
[21]张晓东,凌琪华,聂红明,等.慢性乙型肝炎肝郁脾虚证的logistic回归及判别分析[J].中国中医药信息杂志, 2009, 16(9): 23-24.
[22]宋军路.路志正教授调理脾胃法治疗胸痹心痛的经验研究[D].北京:中国中医科学院, 2008: 20.
[23]刘明芝,周仁郁.中医药统计学与软件应用[M].北京:中国中医药出版社, 2006: 268-284.
[24]袁士宏,王天芳.多元统计方法在建立证候诊断模型研究中存在问题的思考[J].北京中医药大学学报, 2004, 27(4): 9-11.
[1]国际心脏病学会和协会及世界卫生组织临床命名标准化联合专题组.缺血性心脏病的命名及诊断标准[S].中华心血管病杂志, 1981, 9(1): 75-76.
[2]中华医学会心血管病学分会,中华心血管病杂志编辑委员会.慢性稳定性心绞痛诊断与治疗指南[J].中华心血管病杂志, 2007, 35(3): 196.
[3] Campeau L. Letter Crading of angina pectoris. Circulation, 1976, 54(3): 522-523.
[4]黄永生,郭家娟,邓悦.先天伏寒证理论内涵及其对临床指导意义[J].实用中医内科杂志, 2007, 21(6): 3-4.
[5]郑筱萸.中药新药临床研究指导原则[M].北京:中国医药科技出版社, 2002: 68-73.
[6]中国中西医结合学会心血管学会.冠心病中医辨证标准[J].中西医结合杂志, 1991, 11(5): 2-7.
[7]中西医结合治疗冠心病心绞痛及心律失常座谈会.冠心病心绞痛及心电图疗效评定标准[J].医学研究通讯, 1979, (12): 17.
[8]冠心病心绞痛疗效评定标准(1979年修订)[J].医学研究通讯, 1979, 12: 17.
[9]吴岳.董克礼教授诊治中老年冠心病经验[J].湖南中医杂志, 2006, 22(1): 20-22.
[10]颜乾麟.颜德馨审机论治冠心病经验[J].中国中医药信息杂志, 2009, 16(2): 88-89.
[11]曹洪欣,张明雪.试论冠心病病机与阳虚痰瘀[J].中医药通报, 2002, 1(6): 1-3.
[12]中医临床诊疗术语证候部分.中华人民共和国国家标准,国家技术监督局发布. GB/T16751: 5
[13]栗德林,朴胜华.寒热错杂证探微[J].中医药学报, 2003, 31(6): 15-17.
[14]王玉珠,刘国安.治疗胃肠之寒热错杂证的学术思想与经验[J].光明中医, 2000, 15(6): 28-29.
[15]王道成.苦辛通降法的应用体会[J].陕西中医, 2009, 30(11): 1568.
[16]李保双,朱清.周乐年学术思想探讨-中焦虚寒证[J].辽宁中医杂志, 2007, 34(4): 424-425.
[17]王婧,王泽生.刘小北辨治寒热错杂型脾胃病经验[J].中国中医药信息杂志, 2009, 16(5): 84-85.
[18]王永炎,张志斌.再议完善辨证方法体系的几个问题[J].天津中医药, 2007, 24(1): 1-4.
[19]陈世波,刘保延,王永炎,等.“症”及其分类在中医临床评价中的作用分析,中医杂志, 2009, 50(1): 5-7.
[20]王阶,何庆勇,姚魁武,等.冠心病心绞痛病证结合疗效评价标准的研究[J].中医杂志, 2008, 49(9): 842-844.
[21]刘保延,王永炎.证候、证、症的概念及其关系的研究[J].中医杂志, 2007, 48(4): 293-298.
[22]王永炎.中医研究的三个重要趋势[J].天津中医药, 2005, 22(2): 89-91.
[23]张兰凤,王阶,王永炎.方证对应研究[J].中华中医药杂志, 2005, 20(1): 8-10.
[24]魏华凤,季光,郑培永.证候诊断规范化研究的现状分析[J].中西医结合学报, 2007, 5(2): 115-121.
[25]吕爱平,李梢,王永炎.从主观症状的客观规律探索中医证候分类的科学基础[J].中医杂志, 2005, 46(1): 4-6.
[1]臧益民,樊荣.加强多学科协作,争取心血管病研究取得进展[J].心脏杂志, 2006, 18(5): 483-488.
[2]李巧汶.炎症与组织因子在冠心病中的研究进展[J].心血管病学进展, 2008, 29(1): 61-63
[3] Koenig W, Khuseyinova N, Baumert J, et al. Increased concentrations of C-reactive protein and IL-6 but not IL-18 are independently associated with incident coronary events in middle-aged men and women:results from the MONICA/KORA Augsburg case-cohort study, 1984-2002 [J]. Arterioscler Thromb Vasc Biol, 2006, 26(12): 2745-2751.
[4] Pearson TA, Mensah GA, Alexander RW, et al.Markers of inflammation and cardiovascular disease: application to clinical and public health practice:Astatement for health care professionals from the Centers for Disease Control and Prevention and the American Heart Association[J]. Circulation,2003, 107(3): 499-511.
[5] Cushman M, Arnold AM, Psaty BM, et al. C-reactive protein and the 10-year incidence of coronary heart disease in older men and women[ J]. Circulation, 2005, 112:25-31.
[6] Koenig W, Lowel H,Baumert J, et al. C-reactive protein modulates risk prediction based on the Framingham Score: implications for future risk assessment: results from a large cohort study in southern Germany[J]. Circulation, 2004, 109(11): 1349-1353.
[7]崔健昆,那坤. C反应蛋白与冠心病的相关性的研究[J].世界中西医结合杂志, 2010, 5(1): 70.
[8] Mullenix PS, Andersen CA, Starnes BW. Atherosclerosis as inflammation. Ann Vasc Surg, 2005, 19(1): 130-138.
[9] Funayama H, Ishikawa SE,Kubo N, et al. Increases in interleukin-6 and matrix metalloproteinase-9 in the infarct-related coronary artery of acute myocardial infarction[J]. Circ J, 2004, 68(5): 451-454.
[10] Szekanecz Z, Kerekes G, Dér H, et al. Accelerated atherosclerosis in rheumatoid arthritis[J]. Ann N YAcad Sci, 2007, 1108: 349-358.
[11]王育珊,王骥,王广.急性心肌梗死患者缺血-再灌注过程中血清白细胞介素-6、白细胞介素-8的动态变化及意义[J].中华心血管病杂志, 2004, 32:1.
[12] Kleemann R, Zadelaar S, Kooistra T. Cytokines and atherosclerosis: a comprehensive review of studies in mice[J]. Cardiovasc Res, 2008, 79(3): 360-376.
[13] Petrovay F, Heltai K, Kis Z, et al. Chronic infections and histamine, CRP and IL-6 levels after percutaneous trans luminal coronary angioplasty[J]. Inflamm Res, 2007, 56(9): 362-367.
[14] Mysliwska J, Wieckiewicz J, Hak L, et al. Interleukin 6 polymorphism corresponds to the number of severely stenosed coronary arteries[J]. Eur Cytokine Netw, 2006, 17(3): 181-188.
[15]洪永敦,黄衍寿,吴辉,等.冠心病中医证候与炎症因子关系的临床研究[J].广州中医药大学学报, 2005, 22(2): 81-86.
[16]魏海明,田志刚,刘杰冯,等.人外周血单个核细胞表达细胞因子mRNA的临床意义研究[J].临床输血与检验, 2001, 3(l):3-5.
[17]迟小伟,刘杰. hs-CRP,IL-6,TNF-α在心血管疾病中的意义[J].医学检验与临床, 2008, 19(3): 50-51.
[18]佟琳,刘广益,李作孝.应激对神经-内分泌-免疫调节网络的影响[J].医学综述, 2003, 9(11): 686-688.
[19]付义,陈冰.神经-内分泌-免疫(NEI)网络研究促进中西医交融[J].中华中医药学刊, 2008, 26(4): 821-822.
[20]李丛丛.怒志对冠心病心绞痛患者神经-内分泌-免疫机制的研究[D].山东:山东中医药大学. 2008: 16.
[21]张莉.细胞因子在神经-内分泌-免疫网络中的调节机制[J].免疫学杂志, 2006, 22(3): 128-131.
[22]王欣.从神经-内分泌-免疫网络调节探讨中药复方效应机制[J].中医药学刊, 2003, 21(12): 2055.
[23]张焱,回世洋.中医五脏调控系统与神经内分泌免疫调节网络的关系[J]. 2009, 27(1): 188-189.
[24]刘永琦,王文.虚证的免疫学本质[J].中国中医基础医学杂志, 2003, 9(5): 7-10
[25]沈自尹,中医药的一大特色—调节整体,改善局部[J].中国中西医结合杂志, 2006, 26(12): 1122-112
[2]杨传彪,周民权.论补养心阴法是治疗冠心病的重要方法[J].中国中医基础医学杂志, 1998, 4(6): 45-47.
[3]欧阳智兴,欧阳博文.补肾固本对治疗冠心病的作用[J].中国中医药信息杂志, 2002, 9 (4): 7-8.
[4]包培蓉,吕同杰.从火邪论治心绞痛[J].中国中医急症,1994,3(3):120-121.
[5]吴伟,彭锐.冠心病热毒病机的探讨[J].新中医,2007, 39(6): 3-4.
[6]吴伟,邝枣园,黄衍寿,等.肺炎衣原体感染致冠心病的研究进展及中医药防治对策[J].广州中医药大学学报, 2002, 19(1): 77-80.
[7]丁书文,王晓,李运仑.热毒学说在心系疾病中的构建与应用[J].山东中医药大学学报, 2004, 28(61): 413-416.
[8]李晓,姜萍.关于胸痹心痛之郁热伤络病机[J].中医杂志, 2003, 44(8): 636-637.
[9]解民.从肝论治冠心病心绞痛的临床观察[J].吉林中医药, 2002, 22(4): 5.
[10]马爱萍,郭海涛.调肝脾防治中青年心身冠心病的体会[J].辽宁中医杂志, 2005, 32(2): 133-134.
[11]陈可冀,史载祥.实用血瘀证学[M].北京:人民卫生出版社, 1999: 261.
[12]张明雪,曹洪欣,吴东宁.论“血瘀”在冠心病发病中的作用[J].中国中医基础医学杂志, 2009, 15 (2): 128-131.
[13]沈绍功.诊治冠心病的新思路[J].中国中医急症, 1999, 8(2): 51-53.
[14]马宁,安冬青,朱萌,等.秽浊痰阻型冠心病(胸痹)脾胃虚损之探[J].新疆中医药, 2009, 27(1): 13-15.
[15]倪量,杨培君.冠心病“治痰为先”的临床思路探讨[J].中国中医急症, 2004, 13(1): 25-26.
[16]张明雪,曹洪欣,常艳鹏,等.论“寒邪”在冠心病发病中的作用[J].中医药学报, 2009, 37(3): 1-4.
[17]何庆勇,施展,李霁,等.陈鼎祺教授治疗冠心病的经验[J].时珍国医国药, 2007, 18(11): 2612-2613.
[18]孟繁蕴,翟聚良,张艳东.周次清教授治疗冠心病经验[J].四川中医, 2002, 20(6): 9.
[19]王侠,陈秋雄,昊焕林.《金匮要略》助阳扶正法与冠心病诊治[J].山东中医杂志, 2005, 24(10): 635.
[20]郝现军,王冠民.冠心病证治心得[J].陕西中医学院学报, 2008, 31(1): 28-29.
[21]胡少红.浅谈气虚为冠心病之本[J].吉林中医药, 2005, 25(11): 5-6.
[22]牟大鹏.辨证治疗以胸闷为主症冠心病浅识[J].实用中医内科杂志, 2007, 21(7): 29.
[23]武志平,闫桂玲.益气化痰汤治疗冠心病心绞痛37例[J].陕西中医, 2002, 23(8): 679.
[24]王忠良,钱士明,张寒梅.冠心病不稳定型心绞痛病机初探[J].湖南中医杂志, 2005, 21(6): 58-59.
[25]曹洪欣,张明雪.试论冠心病病机与阳虚痰瘀[J].中医药通报, 2002, 1(6): 1-3.
[26]赵军礼,钟少昕.陈镜合教授从郁论治冠心病经验[J].新中医, 2000, 32(4): 11-12.
[27]冯云萍.冠心病心绞痛的中医治疗体会[J].山西医药杂志, 2007, 36(8): 616-617.
[28]喻秀兰,梅国强.诊治冠心病的经验[J].湖北中医杂志, 2004, 26(10): 17-18.
[29]秦建国.胸痹心痛病机新论[J].辽宁中医杂志, 2004, 31(10): 815-816.
[30]吴焕林,林晓忠,邹旭.邓铁涛治疗冠心病临床经验探析[J].辽宁中医学院学报, 2005, 7(4): 312-313.
[31]吴伟康,邓铁涛.邓老“痰瘀相关”理论与冠心病防治[J].深圳中西医结合杂志, 2006, 16(1): 13-16.
[32]李柳骥,严季澜.试论扶阳在心绞痛治疗中的地位及含义[J].中华中医药杂志(原中国医药学报), 2009, 24 (7): 840-842.
[33]沈金玲.温法治疗老年冠心病探析[J].中医研究, 2008, 21( 6): 6-8.
[34]颜乾麟,颜德馨.审机论治冠心病经验[J].中国中医药信息杂志. 2009, 16(2): 88-89.
[35]樊瑞红,马连珍.温阳活血法治疗冠心病心绞痛经验[J].辽宁中医杂志, 2002, 29(2): 72.
[36]吴岳.董克礼教授诊治中老年冠心病经验[J].湖南中医杂志, 2006, 22(1): 20-22.
[37]赵红.老年冠心病心绞痛的辨治体会[J].光明中医, 2005, 20(1): 10.
[38]姜淑琴.冠心病从肾论治浅谈[J].中国中医急症, 2005, 14(3): 275.
[39]姜春梅,查杰,尹远平,等.五脏一体—论治冠心病学术思想探讨[J].中医药学刊, 2005, 23(4): 597-598.
[40]吴以岭.从络病学说论治冠心病心绞痛[J].中国中医基础医学杂志, 2001, 7(4): 71-74.
[41]王淑芹.益气活血祛风通络治疗冠心病心绞痛100例[J].山东中医杂志, 1995, 14(2): 67-68.
[42]戴国华.冠心病风病说[J].山东中医药大学学报, 2003, 27(3): 172-174.
[43]刘杨,吕懋庸,罗洪林.六经辨治冠心病临证思路探讨[J].四川中医, 2008, 26(8): 28-29.
[44]张光银,张军平.从病证结合谈冠心病大气下陷证[J].吉林中医药, 2009, 29(4): 283-284.
[45]张京春,谢元华,蒋跃绒,等.陈可冀辨治冠心病医案证法方药的频数分析[J].中医杂志, 2008, 49(10): 901-902.
[46]吴荣,王阶,任廷革,等.基于数据挖掘的名老中医冠心病诊疗规律研究[J].中华中医药学刊, 2008, 26(12): 2581-2583.
[1]中国中西医结合学会心血管学会.冠心病的中医辨证标准[S].中西医结合杂志, 1991, 11(5): 257.
[2]陈贵廷,薛赛琴.最新国内外痰病诊疗标准[S].北京:学苑出版社. 1992: 209-212.
[3]吴凯.国家中医药管理局医政司胸痹急症协作组[J].中国中医急症, 1994, 3(1): 47.
[4]中华人民共和国卫生部.中药新药临床研究指导原则[M].北京:人民卫生出版社, 1993: 41-45.
[5]国家中医药管理局.中医病证诊断疗效标准[S].南京:南京大学出版社, 1994: 18-19.
[6]中华人民共和国卫生部.中药新药治疗冠心病心绞痛的临床研究指导原则(试行)[M].北京:中国医药科技出版社, 2002: 68-73.
[7]王永炎.中医内科学[M]. 6版.上海:上海科学技术出版社, 1997: 108-117.
[8]周仲瑛.中医内科学[M]. 7版.北京:中医药出版社, 2007: 135-146.
[9]吴旸,王轩,崔杰,等. 348例冠心病患者中医证候特点因子分析[J].中华中医药学刊, 2009, 27(2): 392-394.
[10]吴焕林,阮新民,杨小波,等. 319例冠心病患者证候分布规律分析[J].中国中西医结合杂志, 2007, 27(6): 498-500.
[11]贾振华,王永军,吴以岭,等.基于熵的复杂系统分划方法与冠心病心绞痛证候要素提取及其分布规律[J].第二军医大学学报, 2007, 28(7): 775-777.
[12]王阶,邢雁伟,姚魁武,等.冠心病心绞痛中医证候要素研究及临床应用[J].湖北中医学院学报, 2009, 11(3): 3-5.
[13]王晓才,农一兵,林谦,等. 138例冠心病患者的证候分布与组合特点分析[J].中医杂志, 2008, 49(1): 62-66.
[14]郑峰,曲丹,徐浩,等.冠心病稳定期患者中医辨证与超敏C反应蛋白相关性研究[J].中国中西医结合杂志, 2009, 29(6): 485-488.
[15]商秀洋,石洁.冠心病中医辨证与血清高敏C反应蛋白的关系研究现代中西医结合杂志[J]. 2008, 17(6): 818-819.
[16]张继红,苗志林,刘冬梅,等.冠心病中医证型与血管内皮功能指标的相关性分析[J].心血管康复医学杂志, 2006, 15(2): 186-187.
[17]王阶,邢雁伟,陈建新,等. 1069例冠心病患者冠状动脉造影与中医证候特点[J].中西医结合学报, 2008, 6(2): 148-152.
[18]董国菊,刘剑刚,王承龙,等. 300例冠心病患者中医证型分布特点分析[J].环球中医药, 2009, 2(2): 96-98.
[19]何庆勇,王阶,张允岭,等.女性冠心病中医证候学及冠脉病变特点研究[J].中国中西医结合杂志, 2009, 29(10): 879-882.
[20]何庆勇,王阶,姚魁武,等. 1069例冠心病脏腑虚证的多中心前瞻性研究[J].中华中医药杂志(原中国医药学报), 2009, 24(1): 31-33.
[21]吴辉,于扬文,吴伟,等. 116例冠心病患者中医证候及病因分析[J].江苏中医药, 2004, 25(10): 30-31.
[22]张京春,谢元华,蒋跃绒,等.陈可冀辨治冠心病医案证法方药的频数分析[J].中医杂志, 2008, 49(10): 901-902.
[23]吴荣,王阶,任廷革,等.基于数据挖掘的名老中医冠心病诊疗规律研究[J].中华中医药学刊, 2008, 26(12): 2581-2583.
[24]王阶,吴荣,周雪忠.基于支持向量机的名老中医治疗冠心病证候要素研究[J].北京中医药大学学报, 2008, 31(8): 540-543.
[25]其其格,王伟,胡立胜,等. 9790例冠心病心绞痛辨证分型文献统计分析[J].山酉中医, 2008, 24(10): 31-33.
[26]李军,王阶.冠心病心绞痛证候要素与应证组合的5099例文献病例分析[J].中国中医基础医学杂志, 2007, 13(12): 926-930.
[27]陈一清,吴礼胜.冠心病心绞痛辨证施治若干问题探讨[J].中国中医急症, 2005, 14(7): 654-656.
[28]张琳,于鑫婷,徐浩.冠心病中医证候特点的分析与思考[J].中西医结合心脑血管病杂志, 2009, 7(5): 578-581.
[29]管恩泽,朱萱萱,王广基,等.冠心病中医辨证分型与临床指标相关性研究[J].中华中医药学刊, 2008, 26(10): 2249-2251.
[30]王宇军,胡利荣.冠心病患者冠状动脉CTA与中医辨证分型关系分析[J].浙江中医杂志, 2009, 44(6): 408.
[31]邢雁伟,李尊,王阶,等.冠脉病变特征和中医证候要素关系的研究[J].辽宁中医杂志, 2008, 35(l): 36-38.
[32]王子宽,柳荫,刘军,等.冠心病患者冠状动脉病变范围及狭窄程度与中医证型相关性分析[J].陕西中医, 2009, 30(2): 134-135.
[33]林冬群,曾敏然,林宇,等.冠心病患者冠状动脉搭桥手术围手术期中医证候分布和演变规律初探[J].广州中医药大学学报, 2009, 26(2): 188-190.
[34]王阶,李军,姚魁武,等.冠心病心绞痛证候要素和冠脉病变的Logistic回归分析[J].辽宁中医杂志, 2007, 34(9): 1209-1211.
[35]徐浩,鹿小燕,陈可冀,等.血瘀证及其兼证与冠脉造影所示病变及介入治疗后再狭窄的相关性研究[J].中国中西医结合杂志, 2007, 27(1): 8-13.
[36]杜建强,吴万垠,毛炜,等. SPECT在冠心病中医辨证中的应用[J].中医药临床杂志, 2007, 1(3): 282-283.
[37]丁邦晗,杨敏,周珂,等.胸痹心痛患者心电图改变与中医证型的关系[J].中国中西医结合急救杂志, 2008, 15(1): 31-33.
[38]戴跃龙,李方洁,杨阳.气阴两虚证(冠心病、糖尿病)心率变异性时域指标研究[J].黑龙江中医药, 2009, 38(6): 4-5.
[39]王玉燕,杜武勋,魏营,等.冠心病不同证型与颈动脉内-中膜厚度关系的研究[J].山西中医, 2009, 25(2): 34-36.
[40]杨东辉,孙博,郭艳艳.冠心病患者中医证型与颈动脉内膜-中层厚度及踝臂指数的相关性研究[J].云南中医中药杂志, 2009, 30(9): 5-6.
[41]褚田明,顾仁樾.冠心病阳虚证与心功能减退关系的研究-附262例临床资料[J].江苏中医药, 2007, 39(6): 17-18.
[42]唐巍,遇红,李江涛.冠心病患者血中胰岛素、胰高血糖素与中医证候类型关系的研究[J].中国中医基础医学杂志, 2002, 8(9): 53/693-55/695.
[43]郭平清,林求诚,郭银庚,等.高密度脂蛋白磷脂对冠心病肾阳虚证的诊断作用[J].中国中西医结合急救杂志, 2003, 10(4):223-225.
[44]赵明君,薛强,雷瑗琳.冠心病患者血清瘦素水平与中医证候的相关性研究[J].陕西中医, 2008, 29(2): 132-133.
[45]龙卫平,石磊,韦爱欢,等.冠心病中医辨证分型与内皮损伤、炎症反应及血小板活化的相关性研究[J].广州中医药大学学报, 2008, 25(5): 457-460.
[46]袁肇凯,黄献平,谭光波,等.冠心病血瘀证血管内皮细胞功能的检测分析[J].中国中西医结合杂志, 2006, 26(5): 407-410.
[47]杨徐杭,汶医宁,党琳,等.冠心病中医辨证与血清E-选择素、细胞间粘附分子-1的关系研究[J].四川中医, 2008, 26(1): 61-62.
[48]袁肇凯,黄献平,简维雄,等.冠心病辨证与血凝纤溶系统关系的临床研究[J].云南中医学院学报, 2009, 32(3): 1-4.
[49]杨徐杭,汶医宁,王军威.肺炎衣原体感染与冠心病中医证候的关系[J].陕西中医学院学报, 2009, 32(1): 20-21.
[50]杨徐杭,汶医宁,王军威,等.冠心病中医辨证与血清IL-18、sCD40L的关系[J].江苏中医药, 2009, 41(3):31-32.
[51]卢玉俊,石磊.冠心病中医证型与血浆同型半胱氨酸水平相关性的研究[J].浙江中医药大学学报, 2009, 33(1): 103-104.
[52]杨徐杭,汶医宁,王军威.基质金属蛋白酶-9与冠心病中医证候的关系[J].陕西中医, 2009, 30(2): 131-132.
[53]杨军辉,欧阳玉燕.内皮细胞损伤与冠心病心绞痛血瘀证四亚型的相关性研究[J].中国中医药现代远程教育, 2009, 7(5): 14-16.
[54]杨保林,王阶,姜燕.冠心病血瘀证相关基因b13的筛查和临床验证[J].中国中医基础医学杂志, 2007, 13(1): 69-71.
[55]杨保林,王阶,姜燕.冠心病血瘀证相关基因研究[J].世界科学技术-中医药现代化基础研究, 2005,7(1):16-19.
[56]李炜弘,王米渠,王刚,等.冠心病心阳虚证相关差异表达基因分析[J].现代中西医结合杂志, 2004, 13( 24): 3219-3222.
[57]洪永敦,朱会英,陈宇鹏,等.冠心病痰瘀证候与E选择素G98T及S128R基因多态性的关系研究[J].广州中医药大学学报, 2009, 26(1): 1-5.
[58]赵慧辉,候娜,王伟,等.冠心病气虚血瘀证的蛋白质组学特征研究[J].中国中西医结合杂志, 2009, 29(6): 489-492.
[59]杨俊华,杨国靖,刘茹.冠心病患者A型性格与情绪障碍及中医辨证分型关系的探讨[J].中国中医药信息杂志, 2009, 16(8): 23-25.
[1]黄永生,郭家娟,邓悦.先天伏寒证理论内涵及其对临床指导意义[J].实用中医内科杂志, 2007, 21(6): 3-4.
[2]任继学.伏邪探微[J].长春中医学院学报, 2005, 21(1): 4-7.
[3]恩格斯.自然辩证法[M].北京,人民出版社, 1971: 218.
[4]张晓华,黄永生.稳心2号方治疗冠心病心绞痛临床80例观察[J].中国社区医师, 2005, 6(7): 44-46.
[5]黄永生.冠心病心绞痛临床诊治体会[J].长春中医学院学报, 2005, 21(1): 16-17.
[6]于双成,张元秋,袁长吉.从科学假说与临床诊断的相似性阐述类比推理方法学意义[J].中国高等医学教育, 2009, (5): 94-95.
[7]贾春华,王永炎,黄启福,等.从逻辑的观点看-“以象为素,以素为候,以候为证”[J].北京中医药大学学报, 2006, 29(1): 5-7.
[8]王永炎,张志斌.再议完善辨证方法体系的几个问题[J].天津中医药, 2007, 24(1): 1-4.
[9]刘保延,王永炎.证候、证、症的概念及其关系的研究[J].中医杂志, 2007, 48(4): 293-298.
[10]王永炎,张启明,张志斌.证候要素及其靶位的提取[J].山东中医药大学学报, 2006, 30(1): 6-7.
[11]吴荣,王阶,任廷革,等.基于数据挖掘的名老中医冠心病诊疗规律研究[J].中华中医药学刊, 2008, 26(12): 2581-2583.
[12]吉瑞瑞,李付英,张雪静,等.淫羊藿苷对缺氧诱导血管内皮细胞损伤的保护作用[J].中国中西医结合杂志, 2005, 25(6): 525-530.
[13]李梨,周岐新,杨俊卿,等.淫羊藿苷和尼莫地平对脑缺血再灌小鼠行为学变化的影响[J].中国行为医学科学, 2005, 14(8): 687-689.
[14]武敬亮,苏智先,田桂香,等.淫羊藿研究新进展[J].中医药学报, 2004, (3): 134.
[15]付嘉,熊彬,郑冰生,等.巴戟天对D-半乳糖致衰老小鼠抗氧化系统作用的实验研究[J].中国老年学杂志, 20004, 24: 1206.
[16]赵胜,冯国清,付润芳,等.巴戟天水提物对大鼠心肌缺血再灌注损伤的保护作用[J].浙江中医杂志, 2005, 40(3): 124-126.
[17]张贺鸣,韩联合,冯国清,等.巴戟天对培养乳鼠心肌细胞缺氧复氧损伤的防护作用[J].河南中医学院学报, 2005, 20(8): 20-21.
[1]国际心脏病学会和协会及世界卫生组织临床命名标准化联合专题组.缺血性心脏病的命名及诊断标准[S].中华心血管病杂志, 1981, 9(1): 75-76.
[2]黄永生,郭家娟,邓悦.先天伏寒证理论内涵及其对临床指导意义[J].实用中医内科杂志, 2007, 21(6): 3-4.
[3]刘保延,王永炎.证候、证、症的概念及其关系的研究[J].中医杂志, 2007, 48(4): 293-298.
[4]王永炎,张志斌.再议完善辨证方法体系的几个问题[J].天津中医药, 2007, 24(1): 1-4.
[5]吕爱平,李梢,王永炎.从主观症状的客观规律探索中医证候分类的科学基础[J].中医杂志, 2005, 46(1): 4-6.
[6]王映辉,姜在旸,刘保延,等.基于信息和数据挖掘技术的名老中医临床诊疗经验研究思路[J].世界科学技术-中医药现代化, 2005, 7(1): 98-105.
[7]袁世宏,王米渠,王天芳,等.聚类分析对肾虚症状的探索性研究[J].北京中医药大学学报, 2006, 29(4): 254-257.
[8]魏华凤,季光,郑培永.证候诊断规范化研究的现状分析[J].中西医结合学报, 2007, 5(2): 115-121.
[9]于春光.基于多种数据分析方法的慢性乙型肝炎证候要素的研究[D].北京:北京中医药大学, 2007: 1-4.
[10]王泓午,王玉来,金章安,等.缺血性中风发病前7~30 d内症状的病例对照研究[J].天津中医药, 2004, 21(6): 470-473.
[11]李永健,方肇勤,唐辰龙,等. 154例原发性肝癌临床症状多元Logistic回归分析[J].中国中医基础医学杂志, 2003, 9(8): 59-62.
[12]陈建设,谢世平,许前磊,等.艾滋病常见实证量化诊断的Logistic回归分析[J].中医杂志, 2009, 50(7): 632-634.
[13]陈建设,陈文垲.聚类分析结合logistic回归分析在中医证候诊断量化研究中的应用探讨[J].中国卫生统计, 2009, 26(4): 379-381.
[14]王红玉.亚健康状态378例40项症状分析述评[J].中医药学刊, 2004, 22(4): 624-625.
[15]王莹莹,杨金生. 216例中风病急性期痰热腑实证患者症状分析[J].北京中医药大学学报, 2008, 31(5): 347-350.
[16]范军铭,董永书,王守富. 1760例高血压患者中医症状分析[J].中国中医基础医学杂志, 2009, 15(6): 452-454.
[17]李峰,关静,黄焕光,等.静脉吸毒感染HIV与吸毒人群症状分布特征的病例对照研究[J].北京中医药大学学报, 2006, 29(6): 422-425.
[18]吴秀艳,王天芳,陈建新,等.基于关联度法的抑郁症、慢性乙型肝炎、慢性肾功能衰竭病性类证候要素与症状相关性的研究[J].天津中医药, 2009, 26(5): 433-435.
[19]何羿婷,查青林,阎小萍,等.类风湿性关节炎症状因子分析及其与疗效的关系[J].中国中西医结合杂志, 2005, 25(12): 1077-1081.
[20]李建婷,邓兆智,郭新峰,等.类风湿性关节炎中医证候诊断中特征信息的选择[J].广州中医药大学学报, 2009, 26(4): 398-401.
[21]张晓东,凌琪华,聂红明,等.慢性乙型肝炎肝郁脾虚证的logistic回归及判别分析[J].中国中医药信息杂志, 2009, 16(9): 23-24.
[22]宋军路.路志正教授调理脾胃法治疗胸痹心痛的经验研究[D].北京:中国中医科学院, 2008: 20.
[23]刘明芝,周仁郁.中医药统计学与软件应用[M].北京:中国中医药出版社, 2006: 268-284.
[24]袁士宏,王天芳.多元统计方法在建立证候诊断模型研究中存在问题的思考[J].北京中医药大学学报, 2004, 27(4): 9-11.
[1]国际心脏病学会和协会及世界卫生组织临床命名标准化联合专题组.缺血性心脏病的命名及诊断标准[S].中华心血管病杂志, 1981, 9(1): 75-76.
[2]中华医学会心血管病学分会,中华心血管病杂志编辑委员会.慢性稳定性心绞痛诊断与治疗指南[J].中华心血管病杂志, 2007, 35(3): 196.
[3] Campeau L. Letter Crading of angina pectoris. Circulation, 1976, 54(3): 522-523.
[4]黄永生,郭家娟,邓悦.先天伏寒证理论内涵及其对临床指导意义[J].实用中医内科杂志, 2007, 21(6): 3-4.
[5]郑筱萸.中药新药临床研究指导原则[M].北京:中国医药科技出版社, 2002: 68-73.
[6]中国中西医结合学会心血管学会.冠心病中医辨证标准[J].中西医结合杂志, 1991, 11(5): 2-7.
[7]中西医结合治疗冠心病心绞痛及心律失常座谈会.冠心病心绞痛及心电图疗效评定标准[J].医学研究通讯, 1979, (12): 17.
[8]冠心病心绞痛疗效评定标准(1979年修订)[J].医学研究通讯, 1979, 12: 17.
[9]吴岳.董克礼教授诊治中老年冠心病经验[J].湖南中医杂志, 2006, 22(1): 20-22.
[10]颜乾麟.颜德馨审机论治冠心病经验[J].中国中医药信息杂志, 2009, 16(2): 88-89.
[11]曹洪欣,张明雪.试论冠心病病机与阳虚痰瘀[J].中医药通报, 2002, 1(6): 1-3.
[12]中医临床诊疗术语证候部分.中华人民共和国国家标准,国家技术监督局发布. GB/T16751: 5
[13]栗德林,朴胜华.寒热错杂证探微[J].中医药学报, 2003, 31(6): 15-17.
[14]王玉珠,刘国安.治疗胃肠之寒热错杂证的学术思想与经验[J].光明中医, 2000, 15(6): 28-29.
[15]王道成.苦辛通降法的应用体会[J].陕西中医, 2009, 30(11): 1568.
[16]李保双,朱清.周乐年学术思想探讨-中焦虚寒证[J].辽宁中医杂志, 2007, 34(4): 424-425.
[17]王婧,王泽生.刘小北辨治寒热错杂型脾胃病经验[J].中国中医药信息杂志, 2009, 16(5): 84-85.
[18]王永炎,张志斌.再议完善辨证方法体系的几个问题[J].天津中医药, 2007, 24(1): 1-4.
[19]陈世波,刘保延,王永炎,等.“症”及其分类在中医临床评价中的作用分析,中医杂志, 2009, 50(1): 5-7.
[20]王阶,何庆勇,姚魁武,等.冠心病心绞痛病证结合疗效评价标准的研究[J].中医杂志, 2008, 49(9): 842-844.
[21]刘保延,王永炎.证候、证、症的概念及其关系的研究[J].中医杂志, 2007, 48(4): 293-298.
[22]王永炎.中医研究的三个重要趋势[J].天津中医药, 2005, 22(2): 89-91.
[23]张兰凤,王阶,王永炎.方证对应研究[J].中华中医药杂志, 2005, 20(1): 8-10.
[24]魏华凤,季光,郑培永.证候诊断规范化研究的现状分析[J].中西医结合学报, 2007, 5(2): 115-121.
[25]吕爱平,李梢,王永炎.从主观症状的客观规律探索中医证候分类的科学基础[J].中医杂志, 2005, 46(1): 4-6.
[1]臧益民,樊荣.加强多学科协作,争取心血管病研究取得进展[J].心脏杂志, 2006, 18(5): 483-488.
[2]李巧汶.炎症与组织因子在冠心病中的研究进展[J].心血管病学进展, 2008, 29(1): 61-63
[3] Koenig W, Khuseyinova N, Baumert J, et al. Increased concentrations of C-reactive protein and IL-6 but not IL-18 are independently associated with incident coronary events in middle-aged men and women:results from the MONICA/KORA Augsburg case-cohort study, 1984-2002 [J]. Arterioscler Thromb Vasc Biol, 2006, 26(12): 2745-2751.
[4] Pearson TA, Mensah GA, Alexander RW, et al.Markers of inflammation and cardiovascular disease: application to clinical and public health practice:Astatement for health care professionals from the Centers for Disease Control and Prevention and the American Heart Association[J]. Circulation,2003, 107(3): 499-511.
[5] Cushman M, Arnold AM, Psaty BM, et al. C-reactive protein and the 10-year incidence of coronary heart disease in older men and women[ J]. Circulation, 2005, 112:25-31.
[6] Koenig W, Lowel H,Baumert J, et al. C-reactive protein modulates risk prediction based on the Framingham Score: implications for future risk assessment: results from a large cohort study in southern Germany[J]. Circulation, 2004, 109(11): 1349-1353.
[7]崔健昆,那坤. C反应蛋白与冠心病的相关性的研究[J].世界中西医结合杂志, 2010, 5(1): 70.
[8] Mullenix PS, Andersen CA, Starnes BW. Atherosclerosis as inflammation. Ann Vasc Surg, 2005, 19(1): 130-138.
[9] Funayama H, Ishikawa SE,Kubo N, et al. Increases in interleukin-6 and matrix metalloproteinase-9 in the infarct-related coronary artery of acute myocardial infarction[J]. Circ J, 2004, 68(5): 451-454.
[10] Szekanecz Z, Kerekes G, Dér H, et al. Accelerated atherosclerosis in rheumatoid arthritis[J]. Ann N YAcad Sci, 2007, 1108: 349-358.
[11]王育珊,王骥,王广.急性心肌梗死患者缺血-再灌注过程中血清白细胞介素-6、白细胞介素-8的动态变化及意义[J].中华心血管病杂志, 2004, 32:1.
[12] Kleemann R, Zadelaar S, Kooistra T. Cytokines and atherosclerosis: a comprehensive review of studies in mice[J]. Cardiovasc Res, 2008, 79(3): 360-376.
[13] Petrovay F, Heltai K, Kis Z, et al. Chronic infections and histamine, CRP and IL-6 levels after percutaneous trans luminal coronary angioplasty[J]. Inflamm Res, 2007, 56(9): 362-367.
[14] Mysliwska J, Wieckiewicz J, Hak L, et al. Interleukin 6 polymorphism corresponds to the number of severely stenosed coronary arteries[J]. Eur Cytokine Netw, 2006, 17(3): 181-188.
[15]洪永敦,黄衍寿,吴辉,等.冠心病中医证候与炎症因子关系的临床研究[J].广州中医药大学学报, 2005, 22(2): 81-86.
[16]魏海明,田志刚,刘杰冯,等.人外周血单个核细胞表达细胞因子mRNA的临床意义研究[J].临床输血与检验, 2001, 3(l):3-5.
[17]迟小伟,刘杰. hs-CRP,IL-6,TNF-α在心血管疾病中的意义[J].医学检验与临床, 2008, 19(3): 50-51.
[18]佟琳,刘广益,李作孝.应激对神经-内分泌-免疫调节网络的影响[J].医学综述, 2003, 9(11): 686-688.
[19]付义,陈冰.神经-内分泌-免疫(NEI)网络研究促进中西医交融[J].中华中医药学刊, 2008, 26(4): 821-822.
[20]李丛丛.怒志对冠心病心绞痛患者神经-内分泌-免疫机制的研究[D].山东:山东中医药大学. 2008: 16.
[21]张莉.细胞因子在神经-内分泌-免疫网络中的调节机制[J].免疫学杂志, 2006, 22(3): 128-131.
[22]王欣.从神经-内分泌-免疫网络调节探讨中药复方效应机制[J].中医药学刊, 2003, 21(12): 2055.
[23]张焱,回世洋.中医五脏调控系统与神经内分泌免疫调节网络的关系[J]. 2009, 27(1): 188-189.
[24]刘永琦,王文.虚证的免疫学本质[J].中国中医基础医学杂志, 2003, 9(5): 7-10
[25]沈自尹,中医药的一大特色—调节整体,改善局部[J].中国中西医结合杂志, 2006, 26(12): 1122-112
© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号 地址：北京市海淀区学院路29号 邮编：100083 电话：办公室：(+86 10)66554848；文献借阅、咨询服务、科技查新：66554700 |